# India TB Drug Resistance Mapping

## Overview
Comprehensive analysis of drug resistance patterns in M. tuberculosis from India using whole-genome sequencing data from multiple published studies.

## Key Finding
**45% of TB in India is Pre-XDR** | 7.5% Linezolid-R | 1.0% Bedaquiline-R

## Sample Size
**1,952 isolates** from 4 multicenter studies

## Studies Included
| Study | N | PMID |
|-------|---|------|
| Bhanushali et al. 2024 | 600 | 38597637 |
| Shenoy et al. 2023 | 242 | 37671895 |
| Singh et al. 2022 | 498 | 35442078 |
| Jain et al. 2025 | 612 | 39425905 |

## Author
**Dr. Siddalingaiah H S, MD**  
Professor, Department of Community Medicine  
Shridevi Institute of Medical Sciences, Tumkur, Karnataka, India  
ORCID: [0000-0002-4771-8285](https://orcid.org/0000-0002-4771-8285)

## Repository Structure
```
India_TB_Drug_Resistance/
├── 2_analysis/
│   ├── 01_resistance_analysis.py
│   └── generate_manuscript_expanded.py
├── 3_results/
│   ├── figures/ (3 PNGs)
│   └── tables/ (4 CSVs)
└── 4_manuscript/
    └── Manuscript_India_TB_DrugResistance_EXPANDED_FINAL.docx
```

## License
MIT License
